MYC and BCL2 overexpression is associated with a higher class of Memorial Sloan-Kettering Cancer Center prognostic model and poor clinical outcome in primary diffuse large B-cell lymphoma of the central nervous system

BACKGROUND: Primary diffuse large B-cell lymphoma of the central nervous system (PCNS-DLBCL) is a distinct clinicopathological entity with a poor prognosis. Concurrent MYC and BCL2 overexpression predicts inferior prognosis in systemic DLBCLs. However, the prognostic significance of MYC and BCL2 in...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMC Cancer
Autors principals: Kim, Sehui, Nam, Soo Jeong, Kwon, Dohee, Kim, Hannah, Lee, Eunyoung, Kim, Tae Min, Heo, Dae Seog, Park, Sung Hye, Kim, Chul Woo, Jeon, Yoon Kyung
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2016
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4903010/
https://ncbi.nlm.nih.gov/pubmed/27286976
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-016-2397-8
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars